First published · Last updated
Aspirin exerts anti-tumor effect through inhibiting Blimp1 and activating ATF4/CHOP pathway in multiple myeloma
A 2020 journal article reports that aspirin exerts an anti-tumor effect in multiple myeloma by inhibiting Blimp1 and activating the ATF4/CHOP pathway. The supplied source fields include only the title, publisher, and publication date with no additional experimental details.
Categories: science-and-space, public-health, positive-progress
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 4/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 2/10
- Positivity
- 6/10
- Urgency
- 1/10
Why it matters
Reports a potential mechanism for aspirin's anti-tumor activity in multiple myeloma.

